Font Size:
a
A
A
Keyword [anti- EGFR]
Result: 21 - 40 | Page: 2 of 2
21.
The Effect And Mechanism Of The Fusion Protein Anti-EGFR-iRGD On Radiation Sensitization In Gastric Cancer
22.
Structural And Functional Characterazation Of A Recombinant Anti-EGFR Monoclonal Antibody
23.
Mechanism Of Transferrin Receptor (TFRC) On Radiosensitivity Of Nasopharyngeal Carcinoma (NPC) And Efficacy Of Chemotherapy Combined With Anti-EGFR MAb On Metastatic NPC
24.
Establishment Of Recombinant Protein EGFR-single Domain Antibody-iRGD And Evaluation Of Recombinant Protein Together With Anticancer Drugs In The Treatment Of Gastric Cancer
25.
The Construction Of The Fusion Protein Anti-EGFR-iRGD Decorated Red Blood Cell Membrane Derived Nano-carrier And Its Role In The Targeted Therapy Of Gastric Cancer
26.
Anti-EGFR-PEG-SPIO Nanomolecular Probe In MRgFUS Ablation Lung Adenocarcinoma Model Imaging, Sensitization And Efficacy Monitoring
27.
The Cytotoxicity Of Anti-EGFR Chimeric Antigen Receptor T Cells For Glioma Cell Lines
28.
The Efficacy Of Anti-EGFR Therapy In Patients With (K)RAS Wild-type Metastatic Colorectal Cancer
29.
Study On The Pharmacological Activity Of Aconitum Soongaricum Stapf.and Hydrolysis Products In Xinjiang Province Based On The Cell Membrane Chromatography
30.
Antitumor Activity Of Anti-EGFR Chimeric Antigen Receptor T Cells Against Glioblastoma In Vitro And In Vivo
31.
In Vitro Killing Effect Of Anti-EGFR Monoclonal Antibody-modified Gold Nanoparticles On Bladder Cancer T24 Cells Under Near-infrared Irradiation
32.
Molecular Imaging Application Of Radioiodinated Anti-egfr Human Fab On Egfr-overexpressing Tumor Xenografts
33.
Gadolinium Conjugate Of Bispecific Fusion Protein Anti-EGFR-iRGD As A MRI Contrast Agents For Early Detection Of Gastric Cancer:in Vitro And In Vivo Studies
34.
LIMK1 Nuclear Translocation Promotes Tumor Progression And Achieves The Susceptibility From Anti-EGFR Therapies In Hepatocellular Carcinoma
35.
The Design Of Novel Anti-EGFR Antibody-drug Conjugates And Studies On Their Antitumor Effect
36.
Efficacy And Safety Of Maintenance Therapy Contained With Anti-EGFR Monoclonal Antibody In RAS And BRAF Wild-type Metastatic Colorectal Cancer
37.
Association Between The Primary Site Of Head And Neck Squamous Cell Carcinoma And The Efficiecy Of Anti-EGFR Therapy
38.
Investigation On The Site-specific Integration Of Anti-EGFR At The NW_003626341.1 Site In CHO Cells
39.
Roles And Mechanisms Of LncRNA MIR100HG In Regulation Of Anti-EGFR Resistance And Metastasis In Colorectal Cancer
40.
A Systematic Review And Meta-analysis Of The Efficacy And Safety Of Anti-EGFR Antibody "Rechallenge" In Metastatic Colorectal Cancer
<<First
<Prev
Next>
Last>>
Jump to